The effect of ibutilide on retrograde accessory pathway conduction.

Abstract

Ibutilide is a compound with Class III effects marketed for rapid conversion of atrial fibrillation and atrial flutter. The Class III effect is primarily mediated by blockade of the rapid component of the cardiac delayed rectifier of potassium current, Ikr. Ibutilide was used in three patients with concealed accessory pathways during electrophysiological evaluation for ablation of symptomatic atrioventricular reentry tachycardia. Each pathway (mid-septal, left posterior, and left lateral) exhibited a mean retrograde effective refractory period of 240 +/- 20 ms. Each patient had atrioventricular reentry tachycardia that consistently degenerated to recurrent sustained atrial fibrillation. One to two milligrams of intravenous ibutilide converted atrial fibrillation to sinus rhythm and maintained sinus rhythm throughout the procedure. Retrograde accessory pathway conduction was unchanged. Maintenance of sinus rhythm allowed for successful mapping and catheter ablation of the concealed accessory pathways. No direct current cardioversion was needed. In these patients, ibutilide was effective in converting and controlling atrial fibrillation induced by atrioventricular reentry tachycardia without masking retrograde pathway conduction. Antegrade accessory pathway conduction could not be assessed in this study.